B-chronic lymphocytic leukemia - latest developments
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 1
Abstract
B-chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. Research during the last two decades has contributed to better understanding of the biology of the disease. Two subtypes of CLL have been identified, according to the presence or absence of somatic hypermutations of the variable region of the immunoglobulin (IgV) gene. The differences cover the entire course of the disease, including the cellular origin and behavior and the pathophysiology. The most striking difference between the two subtypes is the poorer prognosis of the unmutated form. CLL is a clinically heterogeneous disease with a survival estimate ranging from months to many years. Its heterogeneity reflects the diversity of pathogenic mechanisms that act upon the B-memory cell, including the antigenic stimulation of B-cells, chromosomal abnormalities and gene mutations, and down-regulation of the apoptotic pathways due to survival signals from the tissue microenvironment. No accurate prognosis can be made for patients in the first stages of disease, which creates the need for prognostic markers that enable timely identification of aggressive forms. Apart from the detection of IgV mutations, a procedure that cannot be performed in many peripheral health centers, testing for zeta-associated protein of 70 kDa (ZAP-70) is highly recommended. CLL B-cells, especially those of the unmutated type, express high levels of ZAP-70, indicative of aggressive disease and shorter survival. ZAP-70 testing, combined with other prognostic factors, is expected to play a central role in patient management. Current clinical trials are evaluating chemotherapeutic combination regimens and are also testing the feasibility of bone marrow transplantation, in the hope of accomplishing cure.
Authors and Affiliations
E. TZOURA, P. ROUSSOU
Keywords
Related Articles
- EP ID EP128962
- DOI -
- Views 53
- Downloads 0
Inflammatory mediators in chronic obstructive pulmonary disease: Review of related pathogenic mechanisms and efficacy of novel targeted therapies
Chronic obstructive pulmonary disease (COPD) is a major global health problem which is increasing in prevalence and is now the fourth leading cause of death in the US. The pathophysiological mechanisms that control the d...
Εpilepsy and art
The sight of a man experiencing an epileptic seizure may create various emotions in an observer, such us annoyance, aversion, fear, embarrassment, curiosity, sympathy or sadness. Because of this, through the centuries ep...
The relationship of early atherosclerotic vascular changes with serum lipoprotein(a)<br /> in predialysis chronic renal failure and maintenance hemodialysis patients <br /> <br />
OBJECTIVE Study of the effect of serum plasma Lp(a) levels on early structural atherosclerotic vascular changes in a group of CRF patients not yet on dialysis and end-stage renal disease patients under regular hemodialys...
Epidemiology of deaths from respiratory tract neoplasms. A 20-year study in the Pieria prefecture
OBJECTIVE The World Health Organization (WHO) urges its member countries to present data on the epidemiology of the causes of death. There have been no reports on deaths from neoplasms of the respiratory system in the va...
The beliefs, myths and reality surrounding the word Haema (blood) from Homer tο the present
According to many linguists, the Greek word AIMA (haema, hema, blood) is derived from the ancient Greek verb “αίθω” (aetho), which means “make red-hot, roast” “warm or heat”. In most ipsissina verba, according to this in...